Stem Cells Industry: Segment Analysis by Technology, 2018 – 2030 (USD Million)

Posted on 2023-12-28 by researchinsights in Biotech, Healthcare, Industrial, Pharmaceuticals, Technology // 0 Comments

Stem Cells Industry Data Book – Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030

The global Stem Cells Industry is anticipated to increase at a significant CAGR from 2023 to 2030.

Grand View Research’s Stem Cells Industry databook is a collection of market sizing & forecasts insights, market dynamics & trends, opportunity assessment, regulatory & technology framework, pricing intelligence, competitive benchmarking analyses, and macro-environmental analysis studies. Within the purview of the databook, such information is systematically analyzed and provided in the form of summary presentations and detailed outlook reports on individual areas of research.

Stem Cells Market Insights

The global stem cells market size was valued at USD 13,266.8 million in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 11.4% from 2023 to 2030. The growing development of precision medicine, increase in the number of cell therapy production facilities and rising number of clinical trials are expected to be major driving factors of the market. Recent advances in the stem cells therapeutics and the tissue engineering hold the potential to draw the attention for treatment of several diseases. Furthermore, increasing demand for stem cells banking and rise in research activities pertaining to stem cells production, storage, and characterization are also expected to fuel the revenue growth for the market. Technological improvements in the parent and ancillary market for stem cells usage are some of the other factors that reinforce the expected growth in demand for stem cells over the forecast period.

The COVID-19 pandemic had a positive impact on the market. The application of the products in the treatment of the novel coronavirus has increased the interest of medical researchers, resulting in an increase in clinical trials. Regenerative medicine based on cellular therapies may be a treatment option for patients, resulting in a reduction in mortality and infection rates. Companies and research institutes are collaborating to develop novel treatment options for the disease. For example, Infectious Disease Research Institute and Celularity, announced in April 2020 that the US FDA had approved a clinical trial application to develop cell-based therapy for COVID-19. Hence, growing applications for clinical trials are expected to boost the demand for stem cells during the forecast period.

Order your copy of the Free Sample of “Stem Cells Industry Data Book – Human Embryonic Stem Cells, Induced Pluripotent Stem Cells Production, Mesenchymal Stem Cells and Cancer Stem Cells Market Size, Share, Trends Analysis, And Segment Forecasts, 2023 – 2030” Data Book, published by Grand View Research

Cancer Stem Cells Market Share, by Cancer Forms, 2022 (%)

Cancer Stem Cells Market Insights

The global cancer stem cells market size was valued at USD 2.59 billion in 2022 and it is expected to grow at a CAGR of 12.1% over the forecast period. The increasing prevalence of cancer, increased R&D activities, and adoption of stem cells are some of the major factors driving the market. Currently, oncology therapeutics has entered a new era with conventional therapies such as radiotherapy, chemotherapy, & surgeries on one side and stem cell therapies on another side.

Over the past few years, stem cells have been successfully utilized in immuno-reconstitution and for blood replenishment after tumor development or treatment. Furthermore, these cells have gained significant attention among healthcare entities for their employment as tools for delivering anti-cancer agents and tissue regeneration. A considerable number of entities have reported positive outcomes of using this mode of tumor treatment. While this therapy is receiving huge success in clinical oncology, a substantial number of published studies have mentioned cancer as a “Cancer Stem Cell (CSC) disorder”. Due to the introduction of this novel concept, an enormous potential for anti-CSC therapeutics has been created.

This approach enables comprehensive investigation of essential and poorly understood clinical events in tumor initiation, propagation, relapse, and metastasis. This is considered one of the major factors responsible for increasing interest in the cancer stem cell model. There is accumulating evidence that sheds light on the existence of cancer stem cells and their role in conferring drug resistance. This further allows generating of novel targets to overcome therapeutic resistance by controlling the regulation of these cells. Hence, CSCs, as potential therapeutic targets, enable therapeutic development that effectively combat tumor progression.

Go through the table of content of Stem Cells Industry Data Book to get a better understanding of the Coverage & Scope of the study

Stem Cells Industry Data Book Competitive Landscape

Competitive rivalry in the stem cell industry is high due to the presence of a large number of both well-established players and small- to mid-sized companies as well as CROs in the market space.

Key players operating in the Stem Cells Industry are:

Advanced Cell Technology Inc.
STEMCELL Technologies Inc.
Cellular Engineering Technologies Inc.
CellGenix GmbH
PromoCell GmbH

Check out more Industry Data Books, published by Grand View Research

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Matched content

Editor’s pick